Skip to content
10-Q

Quarterly Report

GROOVE BOTANICALS, INC. GRVE

0001171520-24-000360

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Oct 16, 2024 59.64M sh
Shares Diluted Q2 2025 · Sep 30, 2024 59.64M sh
Shares Diluted Q2 2025 · Sep 30, 2024 59.64M sh
Shares Diluted Q2 2025 · Sep 30, 2023 58.64M sh
Shares Diluted restated Q2 2025 · Sep 30, 2023 58.56M sh
Cash And Equivalents Q2 2025 · Sep 30, 2024 $6.13K
Cash And Equivalents Q2 2025 · Mar 31, 2024 $1.69K
Current Liabilities Q2 2025 · Sep 30, 2024 $947.29K
Current Liabilities Q2 2025 · Mar 31, 2024 $762.7K
Total Liabilities Q2 2025 · Sep 30, 2024 $947.29K
Total Liabilities Q2 2025 · Mar 31, 2024 $762.7K
Current Assets Q2 2025 · Sep 30, 2024 $11.13K
Current Assets Q2 2025 · Mar 31, 2024 $2.14K
Total Assets Q2 2025 · Sep 30, 2024 $11.13K
Total Assets Q2 2025 · Mar 31, 2024 $2.14K
Eps Basic Q2 2025 · Sep 30, 2024 $0.00
Eps Basic Q2 2025 · Sep 30, 2024 $0.00
Eps Basic Q2 2025 · Sep 30, 2023 $0.00
Eps Basic Q2 2025 · Sep 30, 2023 $0.00
Operating Cash Flow restated Q2 2025 · Sep 30, 2023 −$50.82K
Stockholders Equity restated Q2 2025 · Sep 30, 2023 −$625.51K
Stockholders Equity restated Q2 2025 · Jun 30, 2023 −$540.84K
Stockholders Equity restated Q2 2025 · Mar 31, 2023 −$438.3K
Eps Diluted Q2 2025 · Sep 30, 2023 $0.00
Eps Diluted Q2 2025 · Sep 30, 2023 $0.00
Sga Expense restated Q2 2025 · Sep 30, 2023 $21.85K
Sga Expense restated Q2 2025 · Sep 30, 2023 $38.82K
Net Income restated Q2 2025 · Sep 30, 2023 −$30.05K
Net Income restated Q2 2025 · Sep 30, 2023 −$156.27K
Operating Income restated Q2 2025 · Sep 30, 2023 −$27.8K
Operating Income restated Q2 2025 · Sep 30, 2023 −$151.77K